Not Yet Recruiting
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis
NCT07765524
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- The Frist Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Frist Affiliated Hospital of Guangxi Medical university Nanning, Guangxi, China
- Henan Cancer Hospital Zhengzhou, Henan, China